2 completed, 1 terminated, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Deoxyglucose: new trials by email Literature Review of Deoxyglucose trials Research Report on Deoxyglucose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers 2-Deoxyglucose, Placebo - Acute Nasopharyngitis | Phase 1 | Completed | G.ST Antivirals GmbH | 45 | 2022-03-03 | 2023-10-12 |
| A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer 2-deoxyglucose - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Rutgers, The State University of New Jersey | 12 | 2006-11-01 | 2023-12-22 |
| Safety Study of 2DG With Stereotactic Radiosurgery 2-deoxyglucose (2DG) - Intracranial Neoplasms, Neoplasm Metastasis | Phase 1 | Withdrawn | University of Iowa | 2005-10-01 | 2015-04-10 | |
| Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors 2-deoxy-D-glucose (2DG) - Lung Cancer, Breast Cancer | Phase 1 | Completed | Threshold Pharmaceuticals | 50 | 2004-02-01 | 2009-04-29 |
Neoplasms (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Common Cold (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Respiratory Tract Infections (1) · Stomach Neoplasms (1) · Virus Diseases (1)
G.ST Antivirals GmbH (1) · Rutgers, The State University of New Jersey (1) · Threshold Pharmaceuticals (1) · University of Iowa (1)
United States (3) · Austria (1)
John M. Buatti, M.D. (1) · Luis Raez, MD (1) · Robert DiPaola, MD (1)